Differential toxicity of ganciclovir for rat neurons and astrocytes in primary culture following adenovirus-mediated transfer of the HSVtk gene

Gene Therapy

Volumn 4, Issue 1, 1997, Pages 25-31

  Maron, A ^a   Havaux, N ^a   Le Roux, A ^b   Knoops, B ^a   Perricaudet, M ^c   Octave, J N ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b SANOFI   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Adenovirus; Astrocyte; Gene therapy; Herpes simplex thymidine kinase; Neuron

Indexed keywords

GANCICLOVIR; THYMIDINE KINASE;

ADENOVIRUS; ANIMAL CELL; ARTICLE; ASTROCYTE; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; EXPRESSION VECTOR; GENE TRANSFER; HERPES SIMPLEX VIRUS; IMMUNOCYTOCHEMISTRY; NERVE CELL; NERVE CELL CULTURE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SUICIDE GENE;

ADENOVIRIDAE; ANIMALIA; HERPES; SIMPLEXVIRUS;

EID: 0031016270     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300353     Document Type: Article

References (31)

1. Culver KW et al. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 1992; 256: 1550-1552.
2. Barba D, Hardin J, Ray J, Gage FH. Thymidine kinase-mediated killing of rat brain tumors. J Neurosurg 1993; 79: 729-735.
3. Ram Z et al. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res 1993; 53: 83-88.
4. Barba D, Hardin J, Sadelain M, Gage-FH. Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors. Proc Natl Acad Sci USA 1994; 91: 4348-4352.
5. Perez-Cruet MJ et al. Adenovirus-mediated gene therapy of experimental gliomas. J Neurosci Res 1994; 39: 506-511.
6. Chen SH et al. Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc Natl Acad Sci USA 1994; 91: 3054-3057.
7. Izquierdo M et al. Long-term rat survival after malignant brain rumor regression by retroviral gene therapy. Gene Therapy 1995; 2: 66-69.
8. Ross BD, Kim B, Davidson BL. Assessment of ganciclovir toxicity to experimental intracranial gliomas following recombinant adenoviral mediated transfer of the herpes simplex virus thymidine kinase gene by magnetic resonance imaging and proton magnetic resonance spectroscopy. Clin Cancer Res 1995; 1: 651-657.
9. Vincent A et al. Herpes simplex virus thymidine kinase gene therapy for rat malignant brain tumors. Hum Gene Ther 1996; 7: 197-205.
10. Maron A et al. Gene therapy of rat C6 glioma using adenovirus mediated transfer of the herpes simplex virus thymidine kinase gene: long-term follow-up by magnetic resonance Imaging. Gene Therapy 1996; 3: 315-322.
11. Cool V et al. Curative potential of herpes simplex virus thymidine kinase gene transfer in rats with 9L gliosarcoma. Hum Gene Ther 1996; 7: 627-635.
12. Rainov NG et al. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus thymidine kinase ganciclovir paradigm. Cancer Gene Ther 1996; 3: 99-106.
13. Moolten FL, Wells JM. Curability of rumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J Natl Cancer Inst 1990; 82: 297-300.
14. Stratford-Perricaudet LD, Makeh I, Perricaudet M, Briand P. Widespread long-term gene transfer to mouse skeletal muscles and heart. J Clin invest 1992; 90: 626-630.
15. Badie B, Hunt K, Economou JS, Black KL. Stereotactic delivery of a recombinant adenovirus into a C6 glioma cell line in a rat brain tumor. Neurosurgery 1994; 35: 910-916.
16. Boviatsis EJ et al. Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectors. Hum Gene Ther 1994; 5: 183-191.
17. Viola JJ et al. Adenovirally mediated gene transfer into experimental solid brain tumors and leptomeningeal cancer cells. J Neurosurg 1995; 82: 70-76.
18. Le Gal La Salle G et al. An adenovirus vector for gene transfer into neurons and glia in the brain. Science 1993; 259: 988-990.
19. Davidson BL et al. A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nat Genet 1993; 3: 219-223.
20. Bajocchi G, Feldman SH, Crystal RG, Mastrangeli A. Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors. Nat Genet 1993; 3: 229-234.
21. Akli S et al. Transfer of a foreign gene into the brain using adenovirus vectors. Nat Genet 1993; 3: 224-228.
22. Bi WL, Parysek LM, Warnick R, Stambrook PJ. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSVtk retroviral gene therapy. Hum Gene Ther 1993; 4: 725-731.
23. Freeman SM et al. The 'bystander effect': rumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 1993; 53: 5274-5283.
24. Fick J et al. The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro. Proc Natl Acad Sci USA 1995; 92: 11071-11075.
25. Chen CY et al. Effect of herpes simplex virus thymidine kinase expression levels on ganciclovir-mediated cytotoxicity and the 'bystander effect'. Hum Gene Ther 1995; 6: 1467-1476.
26. Mesnil M et al. Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins. Proc Natl Acad Sci USA 1996; 93: 1831-1835
27. Nilaver G et al. Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors after osmotic blood-brain barrier disruption. Proc Natl Acad Sci USA 1995; 92: 9829-9833.
28. Doran SE et al. Gene expression from recombinant viral vectors in the central nervous system after blood-brain barrier disruption. Neurosurgery 1995; 36: 965-970.
29. Murphy TH, Blatter LA, Wier WG, Baraban JM. Rapid communication between neurons and astrocytes in primary cortical cultures J Neurosci 1993; 13: 2672-2679.
30. Brion JP, Guilleminot J, Nunez J. Dendritic and axonal distribution of the microtubule-associated proteins MAP2 and tau in the cerebellum of the nervous mutant mouse. Brain Res Dev Brain Res 1988; 44: 221-232.
31. Hansen MB, Nielson SE, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Meth 1989; 119: 203-210.